Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2011 1
2012 10
2013 79
2014 123
2015 153
2016 149
2017 127
2018 134
2019 128
2020 116
2021 82
2022 89
2023 28

Text availability

Article attribute

Article type

Publication date

Search Results

1,038 results

Results by year

Filters applied: . Clear all
Page 1
Two-day versus seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial.
Messous S, Trabelsi I, Bel Haj Ali K, Abdelghani A, Ben Daya Y, Razgallah R, Grissa MH, Beltaief K, Mezgar Z, Belguith A, Bouida W, Boukef R, Boubaker H, Msolli MA, Sekma A, Nouira S. Messous S, et al. Ther Adv Respir Dis. 2022 Jan-Dec;16:17534666221099729. doi: 10.1177/17534666221099729. Ther Adv Respir Dis. 2022. PMID: 35657073 Free PMC article. Clinical Trial.
Levofloxacin Pharmacokinetics/Pharmacodynamics, Dosing, Susceptibility Breakpoints, and Artificial Intelligence in the Treatment of Multidrug-resistant Tuberculosis.
Deshpande D, Pasipanodya JG, Mpagama SG, Bendet P, Srivastava S, Koeuth T, Lee PS, Bhavnani SM, Ambrose PG, Thwaites G, Heysell SK, Gumbo T. Deshpande D, et al. Clin Infect Dis. 2018 Nov 28;67(suppl_3):S293-S302. doi: 10.1093/cid/ciy611. Clin Infect Dis. 2018. PMID: 30496461 Free PMC article.
Editorial Comment.
Loeb S. Loeb S. Urology. 2015 Jun;85(6):1246. doi: 10.1016/j.urology.2014.12.063. Epub 2015 Apr 8. Urology. 2015. PMID: 25863839 No abstract available.
An evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin-association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the Food and Drug Administration and the European Medicines Agency.
Bennett AC, Bennett CL, Witherspoon BJ, Knopf KB. Bennett AC, et al. Expert Opin Drug Saf. 2019 Nov;18(11):1055-1063. doi: 10.1080/14740338.2019.1665022. Epub 2019 Sep 18. Expert Opin Drug Saf. 2019. PMID: 31500468 Free PMC article. Review.
Levofloxacin-Induced Hyperpigmentation.
Castellanos-González M, González Morales ML, González-Granda Villalobos J. Castellanos-González M, et al. Actas Dermosifiliogr (Engl Ed). 2019 Oct;110(8):700-701. doi: 10.1016/j.ad.2018.04.010. Epub 2019 May 24. Actas Dermosifiliogr (Engl Ed). 2019. PMID: 31133294 English, Spanish. No abstract available.
Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: A phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trial.
Yuan J, Mo B, Ma Z, Lv Y, Cheng SL, Yang Y, Tong Z, Wu R, Sun S, Cao Z, Wu J, Zhu D, Chang L, Zhang Y; Investigator Group of the Phase 3 Study on Oral Nemonoxacin. Yuan J, et al. J Microbiol Immunol Infect. 2019 Feb;52(1):35-44. doi: 10.1016/j.jmii.2017.07.011. Epub 2017 Aug 2. J Microbiol Immunol Infect. 2019. PMID: 30181096 Free article. Clinical Trial.
A randomized, active-controlled, multicentre clinical trial to evaluate the efficacy and safety of oral sitafloxacin versus levofloxacin in Chinese adults with acute uncomplicated or complicated urinary tract infection.
Li Y, Yin Y, Peng X, Zheng H, Fu F, Liu Z, Wu X, Wu X, Zheng S, Chen N, He L, Ren L, Ni Z, Li D, Liang P, Lv X, Zhang Y. Li Y, et al. Ann Med. 2021 Dec;53(1):217-226. doi: 10.1080/07853890.2020.1861322. Ann Med. 2021. PMID: 33331182 Free PMC article. Clinical Trial.
1,038 results